regeneron ceo leonard schleifer: changing the paradigm on drug access and pricing | cnbc
Published 6 years ago • 5.2K plays • Length 8:35Download video MP4
Download video MP3
Similar videos
-
6:48
regeneron pharmaceuticals ceo dr. leonard schleifer | mad money | cnbc
-
4:32
watch cnbc's full interview with regeneron ceo len schleifer
-
3:29
regeneron ceo on the prospects for its eye drug eylea
-
7:38
regeneron ceo on coronavirus drug timeline
-
7:06
regeneron ceo: we want to retain efficacy and eliminate bad side effects with our cancer treatments
-
6:34
regeneron pharmaceuticals ceo: changing medicine | mad money | cnbc
-
2:00
regeneron ceo on the eye drug market | forbes
-
4:10
regeneron ceo: we'll likely have to constantly adapt our antibody cocktail
-
2:02:44
regeneron: the path from basic research to commercial product
-
1:19:08
george yancopoulos, lasker lessons in leadership
-
7:09
what is regeneron covid-19 monoclonal antibody treatment?
-
4:10
regeneron ceo: our antibody treatment helps immune system win battle
-
57:08
q & a with regeneron ceo, dr. leonard schleifer '73 - 2019 cornell entrepreneur of the year
-
8:31
regeneron to buy sanofi's cancer drug in $1b deal
-
1:42
the cholesterol drug of the future? | forbes
-
4:45
regeneron ceo on teaming up with roche to develop covid-19 antibody cocktail
-
0:16
regeneron ceo says the next big thing for biotech isn’t ai, it’s gene therapy
-
6:23
regeneron ceo on fda request for expanded eua of covid antibody drug
-
6:08
regeneron ceo on how antibody cocktail may protect against covid-19
-
0:40
dr. oz asks the co-founder of regeneron how his company’s antibody cocktail works.